RxDoctor Payments Data

Michelle Birkenholz, DO

Obstetrics · Dublin, OHNPI 1083889216

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $24,555 of the $29,833 with a category attached, or 82.3%. Organon accounts for 91.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $16,400 and has fallen 94.3% since, to $938 in 2025. Among obstetrics clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,833in general payments, 2019–2025

Across 82 payments — averaging $363.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$27K
  • Alydia Health$766
  • Hologic Sales And Service, LLC$664
  • Aspira Women's Health Inc$295
  • Therapeuticsmd, Inc.$251
  • Minerva Surgical, Inc$195
  • plus $350 from 9 others

What the payments were for

  • Consulting fees$1,9176%
  • Speaking & faculty fees$24,55582%
  • Travel & lodging$1,5765%
  • Food & beverage$1,7856%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,833 in reported general payments places this provider in the 95th percentile of 39 obstetrics providers in Ohio.

See all obstetrics providers in Ohio

Medicare billing

Part B allowed, 2024
$5,574
Medicare patients
45
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol33$2,177
ValacyclovirValacyclovir Hcl22$496
ProgesteroneProgesterone, Micronized11$371
Oxybutynin Chloride11$12

Paid to pharmacies, not to this prescriber.

Other obstetrics in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →